References
- GreenMENatajaranNO’DonnellDEChronic obstructive pulmonary disease in primary care: an epidemiologic cohort study from the Canadian Primary Care Sentinel Surveillance NetworkCMAJ Open201531E15E22
- García-OlmosLAlberquillaAAyalaVComorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional studyBMC Fam Pract2013141123324308
- Penning-van BeestFvan Herk-SukelMGaleRLammersJWHeringsRThree-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysisResp Med20111052259265
- World Health OrganizationThe Top 10 Causes of DeathGenevaWorld Health Organization2014 Available from: www.who.int/mediacentre/factsheets/fs310/en/Accessed August 5, 2016
- KarnerCChongJPoolePTiotropium versus placebo for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20127CD009285
- RocheNChanezPBronchodilator combinations for COPD: real hopes or a new Pandora’s box?Eur Respir J20134261441144524293415
- FalkJCurrent issues in managing chronic obstructive pulmonary diseasePharm Pract Plus2015242631
- CheyneLIrvin-SellersMJWhiteJTiotropium versus ipratropium bromide for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20139CD009552
- KewKMMavergamesCWaltersJALong-acting beta2-agonists for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201310CD010177
- FarneHACatesCJLong-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary diseaseCochrane Database Syst Rev201510CD008989
- RodrigoGJPlazaVEfficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: a systematic reviewChest2014146230931724556877
- BatemanEDFergusonGTBarnesNDual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEur Respir J20134261484149423722616
- DecramerMAnzuetoAKerwinEEfficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trialsLancet Respir Med20142647248624835833
- CalverleyPAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
- KewKMSeniukovichAInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20143CD010115
- SuissaSPatenaudeVLapiFErnstPInhaled corticosteroids in COPD and the risk of serious pneumoniaThorax201368111029103624130228
- FordESManninoDMGilesWHPrescription practices for chronic obstructive pulmonary disease: findings from the national ambulatory medical care survey 1999–2010COPD201411324725524568285
- SolemCTLeeTAJooMJLambertBLWaltonSMPickardASComplexity of medication use in newly diagnosed chronic obstructive pulmonary disease patientsAm J Geriatr Pharmacother201210211012222280978
- BourbeauJSebaldtRJDayAPractice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE studyCan Respir J2008151131918292848
- KhakbanASinDDFitzgeraldJMTen-year trends in direct costs of COPD: a population-based studyChest2015148364064626043120
- GershonASWangCGuanJVasilevska-RistovskaJCicuttoLToTIdentifying individuals with physician diagnosed COPD in health administrative databasesCOPD20096538839419863368
- O’DonnellDEHernandezPKaplanACanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2008 update – highlights for primary careCan Respir J200815Suppl A1A8A
- Global Initiative for Chronic Obstructive Lung Disease (GOLD)2015Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [updated 2015] Available from: http://www.goldcopd.org/Accessed June 7, 2016
- MakeBDutroMPPaulose-RamRMartonJPMapelDWUnder-treatment of COPD: a retrospective analysis of US managed care and medicare patientsInt J Chron Obstruct Pulmon Dis201271922315517
- Manitoba Drug Benefits & Interchangeability FormularySeniors and Active LivingWinnipegManitoba Health2016 Available from: http://www.gov.mb.ca/health/mdbif/Accessed August 9, 2016
- YuAPGuerinAPonce de LeonDTherapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalersJ Med Econ201114448649621679019
- Public Health Agency of CanadaFast Facts about Chronic Obstructive Pulmonary Disease (COPD): Data Compiled from the 2011 Survey on Living with Chronic Diseases in CanadaOttawaPublic Health Agency of Canada2013 Available from: www.phac-aspc.gc.ca/cd-mc/publications/copd-mpoc/ff-rr-2011-eng.phpAccessed August 5, 2016